冠状动脉CT在免疫介导炎症性疾病心血管风险评估中的应用
本文为叙述性综述,讨论冠状动脉CT在类风湿关节炎、银屑病和系统性红斑狼疮三种常见免疫介导炎症性疾病(IMID)心血管风险分层中的应用。IMID是加速动脉粥样硬化性心血管病的公认危险因素,传统风险评估工具常系统性低估其风险;CT冠状动脉造影(CTCA)提供的冠状动脉斑块信息可能成为该类高危人群的重要临床辅助手段,但其在无症状人群中的再分类和预后改善价值尚不明确。
要点
- IMID患者心血管风险常被传统工具系统性低估,需改进风险分层方法。
- CTCA是疑似心绞痛患者诊断和评估冠状动脉粥样硬化严重程度的一线检查。
- CTCA在IMID高危人群中可能作为心血管风险分层的重要临床辅助手段。
核心结论
- IMID人群心血管风险被传统评估工具系统性低估,导致心血管病负担和死亡率显著增加,亟需改进风险分层以指导他汀等干预。
- CTCA提供的冠状动脉斑块信息在IMID这一高危人群中可能是有价值的临床辅助手段,但其在无症状一般人群中的再分类和长期预后改善作用尚不明确。
研究设计与样本
- 叙述性综述,讨论冠状动脉CT在类风湿关节炎、银屑病和系统性红斑狼疮三种最常见IMID心血管风险分层中的应用。
主要发现
- IMID是加速动脉粥样硬化性心血管病的公认危险因素,尤其在缺乏传统心血管危险因素的年轻个体和女性中。
- 炎症在动脉粥样硬化斑块形成、进展和破裂中起关键作用,多种与动脉粥样硬化相关的炎症通路是IMID患者正在开展的临床试验的治疗靶点。
- 传统风险评估工具在IMID人群中持续系统性低估心血管风险,造成显著超额心血管病负担和死亡。
临床怎么用
- 对IMID患者应认识到传统风险评估工具可能低估心血管风险,考虑改进风险分层以指导他汀和其他预后干预的使用。
- CTCA作为疑似心绞痛患者诊断和评估冠状动脉粥样硬化严重程度的一线检查,其在IMID高危人群风险分层中的辅助价值值得关注。
局限性
- CTCA在一般人群中用于无症状个体再分类和改善长期预后的价值尚不明确。
- 本文为叙述性综述,未提供原始研究数据或定量汇总结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune-mediated inflammatory diseases (IMIDs) are recognised risk factors for accelerated atherosclerotic cardiovascular disease (CVD), particularly in younger individuals and women who lack traditional CVD risk factors. Reflective of the critical role that inflammation plays in the formation, progression and rupture of atherosclerotic plaques, research into immune mechanisms of CVD has led to the identification of a range of therapeutic targets that are the subject of ongoing clinical trials. Several key inflammatory pathways implicated in the pathogenesis of atherosclerosis are targeted in people with IMIDs. However, cardiovascular risk continues to be systematically underestimated by conventional risk assessment tools in the IMID population, resulting in considerable excess CVD burden and mortality. Hence, there is a pressing need to improve methods for CVD risk-stratification among patients with IMIDs, to better guide the use of statins and other prognostic interventions. CT coronary angiography (CTCA) is the current first-line investigation for diagnosing and assessing the severity of coronary atherosclerosis in many individuals with suspected angina. Whether CTCA is also useful in the general population for reclassifying asymptomatic individuals and improving long-term prognosis remains unknown. However, in the context of IMIDs, it is conceivable that the information provided by CTCA, including state-of-the-art assessments of coronary plaque, could be an important clinical adjunct in this high-risk patient population. This narrative review discusses the current literature about the use of coronary CT for CVD risk-stratification in three of the most common IMIDs including rheumatoid arthritis, psoriasis and systemic lupus erythematosus.
引用
- Peverelli M, Maughan RT, Gopalan D, et al. Use of coronarycomputed tomography for cardiovascular risk assessment in immune-mediated inflammatory diseases. Heart. 2024. PMID: 38238078. doi:10.1136/heartjnl-2022-321403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。